Philippe Bernard

Author PubWeight™ 71.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002 5.58
2 A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 2007 2.41
3 Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005 2.15
4 Hearing thresholds and tympanic membrane sequelae in children managed medically or surgically for otitis media with effusion. Arch Pediatr Adolesc Med 2005 2.13
5 Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol 2011 2.03
6 Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 2012 1.94
7 Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Proteins 2003 1.93
8 Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma. J Cutan Pathol 2008 1.50
9 Distinctive features of melanoma and its management in elderly patients: a population-based study in France. JAMA Dermatol 2013 1.49
10 A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol 2009 1.26
11 Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 2010 1.22
12 Response to: mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 2005 1.18
13 Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. Sci Transl Med 2013 1.15
14 Neurological disorders in patients with bullous pemphigoid. Dermatology 2007 1.14
15 Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 2011 1.04
16 Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France. Arch Dermatol 2012 0.98
17 Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002 0.96
18 Neurolymphomatosis associated with Sézary syndrome. Arch Dermatol 2009 0.95
19 BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol 2004 0.94
20 Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie 2005 0.94
21 Discriminating nevus and melanoma on paraffin-embedded skin biopsies using FTIR microspectroscopy. Biochim Biophys Acta 2005 0.93
22 Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood 2004 0.93
23 Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus: Multicenter study of 46 cases. J Am Acad Dermatol 2007 0.93
24 Differential diagnosis of cutaneous carcinomas by infrared spectral micro-imaging combined with pattern recognition. Analyst 2009 0.91
25 Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells. J Invest Dermatol 2006 0.90
26 Elastin receptor (spliced galactosidase) occupancy by elastin peptides counteracts proinflammatory cytokine expression in lipopolysaccharide-stimulated human monocytes through NF-kappaB down-regulation. J Immunol 2007 0.89
27 Pharmacognosy and reverse pharmacognosy: a new concept for accelerating natural drug discovery. IDrugs 2004 0.88
28 Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. J Neurochem 2003 0.87
29 New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias. Haematologica 2007 0.86
30 Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue. J Med Chem 2009 0.86
31 Large compound databases for structure-activity relationships studies in drug discovery. Mini Rev Med Chem 2007 0.86
32 N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine. Mol Cancer Ther 2008 0.86
33 Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors. J Med Chem 2005 0.86
34 Cutaneous malignant melanoma and neurofibromatosis type 1. Melanoma Res 2004 0.85
35 Stromal reaction in cutaneous melanoma. Crit Rev Oncol Hematol 2004 0.85
36 Raman microspectroscopy detects epigenetic modifications in living Jurkat leukemic cells. Epigenomics 2011 0.85
37 P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol 2006 0.84
38 Automation of an algorithm based on fuzzy clustering for analyzing tumoral heterogeneity in human skin carcinoma tissue sections. Lab Invest 2011 0.84
39 Efficacy and Safety of Methotrexate Combined with Low- to Moderate-Dose Corticosteroids for Severe Alopecia Areata. Dermatology 2016 0.83
40 Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review. Mini Rev Med Chem 2005 0.83
41 [Paraneoplastic urticarial vasculitis and renal carcinoma]. Prog Urol 2003 0.83
42 Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arterioscler Thromb Vasc Biol 2005 0.83
43 Chronic pemphigoid gestationis: comparative clinical and immunopathological study of 10 patients. Dermatology 2003 0.81
44 RS3PE revealing recurrent non-Hodgkin's lymphoma. Joint Bone Spine 2004 0.81
45 Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies. J Med Chem 2009 0.80
46 Assessment of bullous pemphigoid disease area index during treatment: a prospective study of 30 patients. Dermatology 2014 0.79
47 Chronic infantile neurological, cutaneous, and articular syndrome with severe early articular manifestations. Pediatr Dermatol 2005 0.79
48 Melanoma, past severe sunburns and multiple solar lentigines of the upper back and shoulders. Dermatology 2008 0.79
49 Efficacy of ω-3 polyunsaturated fatty acids for the treatment of refractory hydroa vacciniforme. Pediatr Dermatol 2011 0.79
50 Amyloid arthropathy and Waldenström macroglobulinemia. Joint Bone Spine 2005 0.78
51 Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. The example of epsilon-viniferin. Curr Drug Discov Technol 2005 0.78
52 Sex-related location of head and neck melanoma strongly argues for a major role of sun exposure in cars and photoprotection by hair. J Invest Dermatol 2013 0.78
53 Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro. Arch Dermatol Res 2003 0.78
54 Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa. Eur J Dermatol 2012 0.78
55 Thiopurine S-methyltransferase genotypic analysis in autoimmune bullous diseases. Eur J Dermatol 2008 0.78
56 Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up. J Am Acad Dermatol 2012 0.78
57 The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol 2010 0.78
58 Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere. Eur J Med Chem 2007 0.77
59 Necrobiotic xanthogranuloma with multiple myeloma. Case report and pathogenic hypotheses. Joint Bone Spine 2005 0.77
60 Polarized Raman microspectroscopy can reveal structural changes of peritumoral dermis in basal cell carcinoma. Appl Spectrosc 2008 0.77
61 Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review. Curr Med Chem 2016 0.77
62 Toward a unified theory of objectification and dehumanization. Nebr Symp Motiv 2013 0.77
63 The metalloprotease-directed shedding of BP 180 (collagen XVII) from human keratinocytes in culture is unaffected by ceramide and cell-matrix interaction. Eur J Dermatol 2002 0.77
64 Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B. Drug Des Devel Ther 2010 0.77
65 Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy. J Am Acad Dermatol 2011 0.77
66 Umbilical metastasis from breast cancer detected by FDG PET. Clin Nucl Med 2009 0.76
67 Probing tumor and peritumoral tissues in superficial and nodular basal cell carcinoma using polarized Raman microspectroscopy. Exp Dermatol 2009 0.76
68 Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzin. Planta Med 2007 0.76
69 Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study. Arch Dermatol 2005 0.76
70 Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice? Arch Dermatol 2011 0.75
71 Mutually induced formation of host-guest complexes between p-sulfonated calix[8]arene and photolabile cholinergic ligands. Angew Chem Int Ed Engl 2002 0.75
72 Efficient synthesis and first regioselective C-3 direct arylation of imidazo[1,2-b]pyrazoles. Chemistry 2012 0.75
73 Papular and annular fixed urticarial eruption: a characteristic skin manifestation in patients with relapsing polychondritis. J Am Acad Dermatol 2011 0.75
74 Ethanolic Extract of Algerian Propolis and Galangin Decreased Murine Melanoma T. Anticancer Agents Med Chem 2016 0.75
75 Long-term survivors in stage IV melanoma: a regional population-based study in France. Eur J Dermatol 2008 0.75
76 Osteoarticular complications of erysipelas. J Am Acad Dermatol 2004 0.75
77 Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients. Dermatology 2015 0.75
78 Bullous pemphigoid associated with acute myocarditis. Dermatology 2002 0.75